Press Releases

  • Sep. 2018
    LEUKOCARE and Xellia Pharmaceuticals partner to discover innovative formulations for the development of value-added anti-infective therapies
  • Jun. 2018
    LEUKOCARE grants a license on its SPS® formulation technology platform to Laboratorios Liomont for development and commercialization of a biosimilar
  • Apr. 2018
    LEUKOCARE and Boehringer Ingelheim enter into a long-term agreement in the field of animal health
  • Mar. 2018
    Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation
  • Sep. 2017
    LEUKOCARE continues to expand and invests in research and development
  • Feb. 2017
    Rentschler and Leukocare announce strategic alliance and equity investment
  • Sep. 2016
    LEUKOCARE grants license to US vaccine company PaxVax
  • Jul. 2016
    Dr. Andreas Rummelt, pharma industry expert and former CEO of Sandoz, was elected as new supervisory board member at LEUKOCARE’s annual shareholder meeting on July 12th.
  • Mar. 2016
    LEUKOCARE launches comprehensive website update
  • Jul. 2015
    LEUKOCARE receives growth capital funding by LifeCare Partners and strengthens its board with industry experts